skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 3
Patent #:
NONE
Issue Dt:
Application #:
15566568
Filing Dt:
10/13/2017
Publication #:
Pub Dt:
04/05/2018
Inventors:
Haitao Ji, Yongqiang Zhang, Logan R. Hoggard, John A. Wisniewski
Title:
SUBSTITUTED N-([1,1'-BIPHENYL]-3-YL)-[1,1'-BIPHENYL]-3-CARBOXAMIDE ANALOGS AS INHIBITORS FOR BETA-CATENIN/B-CELL LYMPHOMA 9 INTERACTIONS
Assignment: 1
Reel/Frame:
045435/0366Recorded: 04/04/2018Pages: 7
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
Exec Dt:
03/21/2018
Exec Dt:
01/17/2018
Exec Dt:
04/02/2018
Exec Dt:
01/29/2018
Assignee:
201 S. PRESIDENT'S CIRCLE
SALT LAKE CITY, UTAH 84112
Correspondent:
D. BRIAN SHORTELL, J.D., PH.D.
999 PEACHTREE STREET
SUITE 1000
ATLANTA, GA 30309
Assignment: 2
Reel/Frame:
045435/0512Recorded: 04/04/2018Pages: 3
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
04/03/2018
Assignee:
615 ARAPEEN DRIVE
SUITE 310
SALT LAKE CITY, UTAH 84108
Correspondent:
D. BRIAN SHORTELL, J.D., PH.D.
999 PEACHTREE STREET
SUITE 1000
ATLANTA, GA 30309
Assignment: 3
Reel/Frame:
048371/0493Recorded: 02/19/2019Pages: 2
Conveyance:
CONFIRMATORY LICENSE (SEE DOCUMENT FOR DETAILS).
Assignor:
Exec Dt:
05/04/2018
Assignee:
504 SCOTT ST.
USAMRMC-JA W81XWH-14-1-0083
FORT DETRICK, MARYLAND 21702-5012
Correspondent:
ELIZABETH A. ARWINE
504 SCOTT ST.
USAMRMC-JA W81XWH-14-1-0083
FORT DETRICK, MD 21702-5012

Search Results as of: 06/20/2024 01:28 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT